Letter concerning “Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival”: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma

Authors: Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Enrico Franceschi

Published: 2023-05-12

DOI: 10.1093/neuonc/noad071

Source: Full article

---

Abstract

No abstract found.